Jon Hamilton

Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience, health risks, and extreme weather.

Following the 2011 earthquake and tsunami in Japan, Hamilton was part of NPR's team of science reporters and editors who went to Japan to cover the crisis at the Fukushima Dai-ichi nuclear power plant.

Hamilton contributed several pieces to the Science Desk series "The Human Edge," which looked at what makes people the most versatile and powerful species on Earth. His reporting explained how humans use stories, how the highly evolved human brain is made from primitive parts, and what autism reveals about humans social brains.

In 2009, Hamilton received the Michael E. DeBakey Journalism Award for his piece on the neuroscience behind treating autism.

Before joining NPR in 1998, Hamilton was a media fellow with the Henry J. Kaiser Family Foundation studying health policy issues. He reported on states that have improved their Medicaid programs for the poor by enrolling beneficiaries in private HMOs.

From 1995-1997, Hamilton wrote on health and medical topics as a freelance writer, after having been a medical reporter for both The Commercial Appeal and Physician's Weekly.

Hamilton graduated with honors from Oberlin College in Ohio with a Bachelor of Arts degree in English. As a student, he was the editor of the Oberlin Review student newspaper. He earned his master's degree in journalism from Columbia University, where he graduated with honors During his time at Columbia, Hamilton was awarded the Baker Prize for magazine writing and earned a Sherwood traveling fellowship.

Pages

Shots - Health News
3:31 pm
Tue February 12, 2013

Folic Acid For Pregnant Mothers Cuts Kids' Autism Risk

Credit iStockphoto.com
Despite public health campaigns urging women in the U.S. to take folic acid, many are still not taking the supplements when they become pregnant.

Originally published on Mon February 25, 2013 12:19 pm

A common vitamin supplement appears to dramatically reduce a woman's risk of having a child with autism.

A study of more than 85,000 women in Norway found that those who started taking folic acid before getting pregnant were about 40 percent less likely to have a child who developed the disorder, researchers reported in the Journal of the American Medical Association.

Read more
Shots - Health News
11:40 pm
Wed January 16, 2013

Mental Health Gun Laws Unlikely To Reduce Shootings

Credit Hans Pennink / Reuters/Landov
State Senator Jeff Klein (L-R), Assembly Speaker Sheldon Silver, Lieutenant Governor Robert Duffy and Senator Andrea Stewart-Cousins congratulate New York Governor Andrew Cuomo after he signed the New York Secure Ammunition and Firearms Enforcement Act on Tuesday.

Originally published on Thu January 17, 2013 10:11 am

States aren't likely to prevent many shootings by requiring mental health professionals to report potentially violent patients, psychiatrists and psychologists say.

Read more
Shots - Health News
1:16 pm
Wed January 9, 2013

Alzheimer's Drug Dials Back Deafness In Mice

Credit The Kobal Collection
If you know some mice that took This Is Spinal Tap too literally, they might want to know about an experiment to restore hearing with a failed Alzheimer's drug.

Originally published on Mon April 8, 2013 7:34 am

If you've spent years CRANKING YOUR MUSIC UP TO 11, this item's for you.

A drug developed for Alzheimer's disease can partially reverse hearing loss caused by exposure to extremely loud sounds, an international team reports in the journal Neuron.

Before you go back to rocking the house with your Van Halen collection, though, consider that the drug has only been tried in mice so far. And it has never been approved for human use.

Read more
Shots - Health News
2:22 pm
Wed December 26, 2012

Despite Uneven Results, Alzheimer's Research Suggests A Path For Treatment

Credit Slide courtesy of the journal Neurology
Brain scans using Amyvid dye to highlight beta-amyloid plaques in the brain. Clockwise from top left: a cognitively normal subject; an amyloid-positive patient with Alzheimer's disease; a patient with mild cognitive impairment who progressed to dementia during a study; and a patient with mild cognitive impairment.

Originally published on Wed December 26, 2012 6:24 pm

It's been a mixed year for Alzheimer's research. Some promising drugs failed to stop or even slow the disease. But researchers also found reasons to think that treatments can work if they just start sooner.

Scientists who study Alzheimer's say they aren't discouraged by the drug failures. "I actually think it was a phenomenal year for research," says Bill Rebeck, a brain scientist at Georgetown University.

Read more
Shots - Health News
2:27 pm
Fri December 21, 2012

Killer's DNA Won't Explain His Crime

Credit iStockphoto.com
A person's DNA can say a lot about a person, but not why someone has committed a horrific crime like mass murder.

Originally published on Fri December 21, 2012 8:21 pm

Connecticut's chief medical examiner, Wayne Carver, has raised the possibility of requesting genetic tests on Adam Lanza, the man responsible for the shootings at Sandy Hook Elementary School.

Carver hasn't said precisely what he may want geneticists to look for, but scientists who study the links between genes and violence say those tests won't reveal much about why Lanza did what he did.

Read more

Pages